Becoming a daughter

Journal of Genetic Counseling

Volumn 15, Issue 3, 2006, Pages 139-143

  Matloff, Ellen T ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale Cancer Genetic Counseling   (United States)

Author keywords

Breast cancer; Cancer genetic counseling; Hereditary cancer

Indexed keywords

AROMATASE INHIBITOR; BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TAMOXIFEN;

ARTHRITIS; ATTITUDE TO ILLNESS; ATTITUDE TO LIFE; BREAST CANCER; CANCER GENETICS; CANCER RESEARCH; CLINICAL PRACTICE; DAUGHTER; GENE EXPRESSION; GENETIC COUNSELING; HOT FLUSH; HUMAN; LIFE EVENT; LIFELONG LEARNING; MASTECTOMY; MOTHER CHILD RELATION; PERSONAL EXPERIENCE; PROFESSIONAL DEVELOPMENT; REVIEW; TREATMENT RESPONSE;

ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENETIC COUNSELING; HUMANS; MASTECTOMY; MOTHER-CHILD RELATIONS; NUCLEAR FAMILY;

EID: 33745620171     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-005-9012-5     Document Type: Review

References (5)

1. Baum, M., Budzar, A., Cuzick, J., Forbes, J., Houghton, J., Klijn, J., et al. (2001). The ATAC (Arimidex, Tamoxifen, Alone, or in Combination) adjuvant breast cancer trial in post-menopausal (PM) women. Paper presented at the 24th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas.
2. Ellis, M., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Janicke, F., et al. (2001). Letrozole is more effective neoadjuvant endocrine therapy than Tamoxifen for ErbB-1 - and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: Evidence from a phase III randomized trial. J Clin Oncol, 19(18), 3808-3816.
3. Lipton, A., Ali, S., Leitzel, K., Demers, L., Chinchilli, V., Engle, L., et al. (2002). Elevated serum HER-2/neu level predicts decreased response to hormone therapy in metastatis breast cancer. J Clin Oncol, 20(6), 1467-1472.
4. Osborne, C., Bardou, V., Hopp, T., Chamness, G., Hilsenbeck, S., Fuqua, S., et al. (2003). Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst, 95(5), 353-361.
5. Veach, P., Bartels, D., & LeRoy, B. (2002). Defining moments: Catalysts for professional development. J. Genet Counseling, 11(4), 277-280.